https://www.live-feeds.com/feed/abbvie-s-biggest-deal-since-2019-could-land-soonContinuously updated, source-cited coverage. https://www.live-feeds.com/feed/abbvie-s-biggest-deal-since-2019-could-land-soonhttps://www.live-feeds.com/feed/abbvie-s-biggest-deal-since-2019-could-land-soon#u12129Thu, 25 Jun 2026 02:06:17 +0000AbbVie announced on Monday it will buy Apogee Therapeutics for $10.9 billion in cash. This acquisition is the company's largest since 2019. The deal provides AbbVie with long-acting immunology and inflammatory disease drug candidates, including an experimental eczema treatment.What's confirmed:AbbVie agreed to acquire Apogee Therapeutics for $10.9 billion.The deal is AbbVie's largest acquisition in more than five years.The acquisition includes long-acting immunology and inflammatory disease drug candidates.The deal includes an experimental eczema drug.Still unconfirmed:The purchase p